Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News In Conversation With Boston Scientific S Global Medical Chief, Ken Stein, Taking The Pulse Of Pulsed Field Ablation is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific's CMO takes the pulse of pulsed field ablation
In conversation with Boston Scientific's global medical chief, Ken Stein, taking the pulse of pulsed field ablation By Conor Hale Oct 29, 2024 1:00pm ... Read More
Boston Scientific's pulsed field ablation delivers safety, procedure ...
In Boston Scientific’s ADVENT trial, 305 patients were randomized to undergo pulsed field ablation, while 302 received either conventional radiofrequency or cryoballoon ablation. Read More
Boston Scientific Presses Its Advantage in Pulsed Field Ablation
Boston Scientific had increased its debt leverage to acquire new products in 2015-16 and reduced debt through 2017-18, only to increase it again in late 2018 to accommodate the acquisition of BTG. Read More
Farapulse boosts Boston Scientific’s Q4 electrophysiology sales ... - MSN
Boston Scientific reported that electrophysiology sales grew 172% in Q4 2024, driven by an uptake of its Farapulse pulsed field ablation (PFA) system. Revealing its Q4 and full-year results, the ... Read More
Boston Scientific Reports Positive Results from Atrial ... - Investopedia
Boston Scientific was the best-performing stock in the S&P 500 after the medical device maker reported positive results from a clinical trial for its system to treat patients with atrial ... Read More
Boston Scientific CMO Discuss Solutions for Health Inequality on Today ...
NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Today's Marketplace (TMP) is proud to announce a featured interview with Boston Scientific (NYSE: BSX) Global Chief Medical Officer, Kenneth Stein, MD, and ... Read More
Why Medical Devices Behemoth Boston Scientific Shares Are ... - Benzinga
Boston Scientific said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get FDA approval in the first quarter of 2024. The randomized AVANT GUARD trial will enroll more than 500 patients ... Read More
How Boston Scientific (sort of) became ‘Minnesota Scientific’ - MSN
It’s now a leader in the multibillion dollar race to treat AFib with pulsed field ablation. The system treated more than 200,000 patients over the course of a year, pulling in more than $1 billion. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus